Search

Geron Corp

Closed

SectorHealthcare

1.48 -1.33

Overview

Share price change

24h

Current

Min

1.45

Max

1.5

Key metrics

By Trading Economics

Income

-13M

-17M

Sales

5.6M

57M

EPS

-0.02

Profit margin

-29.019

Employees

258

EBITDA

-16M

-12M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+186.75% upside

Dividends

By Acuity

Next Earnings

4 Nov 2026

Market Stats

By TradingEconomics

Market Cap

155M

977M

Previous open

2.81

Previous close

1.48

News Sentiment

By Acuity

75%

25%

314 / 340 Healthcare

Geron Corp Chart

Past performance is not a reliable indicator of future results.

Related News

31 Aug 2026, 23:01 UTC

Geron Corp shares are higher in after-market trading, following notable volatility. The stock's movement contrasts with recent lower closes over the past four sessions.

28 Aug 2026, 19:46 UTC

Geron Corp shares are lower today, continuing a three-day decline amid ongoing inflation concerns and recent comments from Fed officials on price stability.

27 Aug 2026, 23:01 UTC

Geron Corp traded roughly flat in after-market hours, remaining effectively unchanged since Thursday's close, with stability indicated by its position above the 20-day moving average.

26 Aug 2026, 19:56 UTC

Geron Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains above its 20-day moving average.

25 Aug 2026, 21:51 UTC

Geron Corp shares declined after market hours, reflecting broader trends amid a sharp drop in crude oil prices. The stock remains near its one-month range high.

24 Aug 2026, 23:46 UTC

Geron Corp shares are higher in after-market trading, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

21 Aug 2026, 19:46 UTC

Geron Corp shares are lower today, reflecting broader market trends, despite remaining above the 20-day moving average and near the upper end of the one-month range.

20 Aug 2026, 23:06 UTC

Geron Corp shares are lower in after-market hours, showing notable volatility while remaining above their 20-day moving average and near the month's upper range.

19 Aug 2026, 19:26 UTC

Geron Corp shares are higher today, continuing a three-day upward trend. The stock remains above its 20-day moving average, indicating strong market positioning.

18 Aug 2026, 21:03 UTC

News

Geron Corporation's shares are lower in after-market trading following the grant of stock options to new employees at an exercise price of $1.53.

17 Aug 2026, 23:56 UTC

Geron Corp shares are higher in after-market trading, reflecting notable strength. The stock is significantly above its 20-day moving average.

14 Aug 2026, 20:02 UTC

Macro Event

Geron Corp shares are lower today amid broader market declines and disappointing U.S. retail sales data, reflecting negative investor sentiment.

13 Aug 2026, 23:36 UTC

Shares of Geron Corp are trading higher in after-market hours, reflecting a strong performance backdrop despite no specific news identified.

12 Aug 2026, 23:36 UTC

Geron Corp shares are higher in after-market trading, reflecting an upward move since Wednesday's close. The stock remains above its 20-day moving average.

11 Aug 2026, 22:52 UTC

Geron Corp shares are lower in after-market trading with no specific news identified. Broader market sentiment was pressured by rising crude oil prices.

10 Aug 2026, 23:06 UTC

Geron Corp shares are higher in after-market hours, reflecting a gain despite mixed market sentiment and geopolitical tensions affecting global energy markets.

7 Aug 2026, 20:03 UTC

Geron Corp shares are sharply lower during Friday's trading session, reflecting a broader market decline with no specific news identified to explain the movement.

6 Aug 2026, 23:06 UTC

Geron Corp shares traded roughly flat in after-market hours, remaining unchanged since Thursday's close amid a strong recent performance backdrop.

5 Aug 2026, 23:31 UTC

Geron Corp shares are lower in after-market hours, continuing a decline that began during regular trading, with no specific news identified.

4 Aug 2026, 23:36 UTC

Geron Corp shares are lower in after-market trading, nearing the bottom of their one-month range and below the 20-day moving average.

3 Aug 2026, 23:06 UTC

Geron Corp shares are lower in after-market hours, continuing a steady decline since Monday's close and remaining below the 20-day moving average.

31 Jul 2026, 20:02 UTC

Geron Corp shares are lower as the Biotechnology sub-sector declines. The stock pulled back from an earlier session high, finishing below its 20-day moving average.

30 Jul 2026, 20:56 UTC

Geron Corp shares are higher in after-market hours, influenced by positive corporate earnings amid broader market uncertainty following the Federal Reserve's interest rate decision.

29 Jul 2026, 19:32 UTC

Macro Event

Geron Corp shares are lower as market volatility rises following the Federal Reserve's interest rate decision amid ongoing economic growth and inflation concerns.

28 Jul 2026, 18:51 UTC

Shares of Geron Corp are lower today amid broader market volatility and uncertainty regarding Federal Reserve decisions. The stock declined since Monday's close.

27 Jul 2026, 23:16 UTC

Geron Corp shares are lower in after-market trading, despite earlier gains, with no specific company news driving the decline.

24 Jul 2026, 19:46 UTC

Geron Corp shares are lower in Friday's session amid broader market volatility and uncertainty from fluctuating oil prices and new U.S. tariffs.

23 Jul 2026, 10:11 UTC

Shares of Geron Corp are higher in pre-market hours, trading above their 20-day moving average. No specific company news was identified.

22 Jul 2026, 18:51 UTC

Geron Corp shares are lower today amid broader market trends, as crude oil prices surge due to geopolitical tensions.

21 Jul 2026, 23:41 UTC

Geron Corp shares are lower in after-market trading, declining to their lowest point since Tuesday's close. No specific news was identified to explain the drop.

Peer Comparison

Price change

Geron Corp Forecast

Price Target

By TipRanks

186.75% upside

12 Months Forecast

Average 4.33 USD  186.75%

High 6 USD

Low 3 USD

Based on 4 Wall Street analysts offering 12 month price targets forGeron Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

4 ratings

3

Buy

1

Hold

0

Sell

Sentiment

By Acuity

314 / 340 Healthcare

News Sentiment

Very Strong Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat